December 01, 1996; 47 (6 Suppl 3) Articles
Role of selegiline in combination therapy of Parkinson's disease
V. V. Myllyla, K. Sotaniemi, O. Maki-Ikola, U. K. Rinne, E. H. Heinonen
First published December 1, 1996, DOI: https://doi.org/10.1212/WNL.47.6_Suppl_3.200S
V. V. Myllyla
K. Sotaniemi
O. Maki-Ikola
U. K. Rinne
Role of selegiline in combination therapy of Parkinson's disease
V. V. Myllyla, K. Sotaniemi, O. Maki-Ikola, U. K. Rinne, E. H. Heinonen
Neurology Dec 1996, 47 (6 Suppl 3) 200S-209S; DOI: 10.1212/WNL.47.6_Suppl_3.200S
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 47 no. 6 Suppl 3 200S-209S
Print ISSN:
Online ISSN:
History:
- First Published December 1, 1996.
Copyright & Usage:
Copyright 1996 by Advanstar Communications Inc.
Author Disclosures
- V. V. Myllyla, MD, PhD,
- K. Sotaniemi, MD, PhD,
- O. Maki-Ikola, MD, PhD,
- U. K. Rinne, MD, PhD and
- E. H. Heinonen, MD, PhD
- V. V. Myllyla, MD, PhD,
- K. Sotaniemi, MD, PhD,
- O. Maki-Ikola, MD, PhD,
- U. K. Rinne, MD, PhD and
- E. H. Heinonen, MD, PhD
- From the Department of Neurology, University of Oulu (Drs. Myllyla and Sotaniemi), Oulu; Orion Corporation (Drs. Maki-Ikola and Heinonen), Turku; and the Department of Neurology, University of Turku (Dr. Rinne), Turku, Finland.
- Address correspondence and reprint requests to Dr. Vilho Myllyla, Associate Professor, Department of Neurology, University of Oulu, FIN-90220 Oulu, Finland.
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan
Related Articles
- No related articles found.